JMP Securities Starts Prelude Therapeutics (PRLD) at Market Outperform, 'Precision Targeting of SMARCA Drives Cell Kill'
Go back to JMP Securities Starts Prelude Therapeutics (PRLD) at Market Outperform, 'Precision Targeting of SMARCA Drives Cell Kill'| (NASDAQ: PRLD) | Delayed: 5.55 +0.19 (3.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.36 | 52 Week High | $ | |||
| Open | $5.45 | 52 Week Low | $ | |||
| Day High | $5.61 | P/E | N/A | |||
| Day Low | $5.15 | EPS | $ | |||
| Volume | 452,124 | |||||

